Sentences with phrase «myeoproliferative neoplasms»

«Prudential's methodical actuary,» as I wrote in Truth, «had gone through his company's own life insurance payouts for the previous year and had discovered that two words kept recurring in the ledgers: malignant neoplasm.»

Once triggered, the «subroutine» of cancer results in a neoplasm (a group of new, cancerous cells) becoming mobile; this is metastasis, responsible for most deaths from cancer.

These experts decided to rename EFVPTC as «noninvasive follicular thyroid neoplasm with papillary - like nuclear features» or NIFTP.

From a u-CT scan and an X-ray, researchers identified a fibrous dysplastic neoplasm — today, the most common form of benign bone tumor in humans — located on a Neandertal left rib fragment that measured 30 mm (4 1/2 inches) long.

The two main causes of death for the cyclists were neoplasms (32.2 %), and cardiovascular diseases (29 %), both occurring less frequently than in the general public (SMRs of 0.56 and 0.67 respectively).

Next on 23andMe's agenda: applying the same approach to rare cancers, such as sarcoma and a group of blood cancers called myeloproliferative neoplasms, that are difficult to study but that might be ideally suited to this kind of analysis.

Contemporary Management of Myeloproliferative Neoplasms Brady L. Stein and Brandon J. McMahon, Eds.

Patients should receive balanced information stressing not only the overall very low risk of progression to malignant neoplasm but also the symptoms that could signal such development and the need to consult their physician,» the study concludes.

Using a fluorescent protein to detect Rgs16 expression, the investigators found that this gene is induced by pancreatic tumor formation starting from its earliest manifestation as ductal neoplasm all the way to advanced solid tumor in a spatially and temporally coincidental manner.

The SC3 tool was then used to analyse single - cell RNA - sequence data from two patients diagnosed with myeloproliferative neoplasm (MPN) blood cancers.

He has extensive experience treating patients with blood cancers and holds a particular interest in chronic myeloid leukemia and myeloproliferative neoplasms, a group of blood cancers related to leukemia.

«The study provides insight into causes and evolution of this complex neoplasm and has identified targets for new treatments,» says Dr. Silvia Beà, first author of the study.

Emma Young dates the oldest known tumour in the human ancestral line — a fibrous dysplastic neoplasm in a Neanderthal...

Pancreatic Intraepithelial Neoplasia (PanIN) and mucinous cystic neoplasm (MCN) also are lesions that precede pancreatic cancer.

A small percentage of patients have serous cystic neoplasms (SCN) that do not harbor malignant potential or progress to cancer.

According to the American Cancer Society, the most common pediatric neoplasms are leukemia, brain and spinal cord tumors, neuroblastomas, Wilms tumors, and lymphoma, including both Hodgkin and non-Hodgkin.

During the follow - up period of approximately 10.6 years, 1,498 neoplasms (0.6 percent) were diagnosed.

Ben - Gurion University of the Negev (BGU) researchers have found that babies born from mothers who underwent fertility treatments are at increased risk of developing many types of pediatric cancers and tumors (neoplasms).

«The research concludes that the association between IVF and total pediatric neoplasms and malignancies is significant,» Prof. Sheiner says.

The incidence rate for neoplasms was highest among children either after IVF (1.5 / 1000) and somewhat lower for OI births (1.0 / 1000) as compared to that of naturally conceived children -LRB-.59 / 1000).

First author Michele T. Yip - Schneider, Ph.D., associate research professor of surgery, and senior author C. Max Schmidt, M.D., Ph.D., MBA, professor of surgery, biochemistry and molecular biology, report this is the first cyst fluid protein biomarker that can differentiate serous cystic neoplasms, a benign type of cystic lesion, from all other cancerous or precancerous cystic lesions without surgery.

The lesions evaluated in this study that can become cancerous are known as intraductal papillary mucinous neoplasms.

These studies revealed that the void's physical characteristics — the type and location of missing bone — were consistent with a fibrous dysplastic neoplasm, a tumor caused by a bone growth disorder, the scientists report online today in PLOS ONE.

According to a new «proof of principle» study published in Aug. 27 issue of Cancer Prevention Research, Moffitt Cancer Center researchers hope to improve pancreatic cancer survival rates by identifying markers in the blood that can pinpoint patients with premalignant pancreatic lesions called intraductal papillary mucinous neoplasms (IPMNs).

The test was less accurate for the less prevalent pancreatic cyst type called mucinous cystic neoplasm (MCN)-- catching only 30 percent of the cases.

Myeloproliferative neoplasms (MPN) are diagnosed in around 3,300 UK patients every year and cause an overproduction of blood cells creating a significant impact on quality - of - life, with symptoms such as night sweats, itching and tiredness.

It is now firmly established that the growth and metastasis of the vast majority of neoplasms are dependent on the formation of adequate vasculature, i.e., angiogenesis (1, 2, 3).

Primary osteosarcomas of the skull are aggressive neoplasms composed of spindle cells producing osteoid which have poor outcome.

Phase I Study of MK - 3475 (Pembrolizumab) in Patients with Human Immunodeficiency Virus (HIV) and Relapsed / Refractory or Disseminated Malignant Neoplasm

Mice have a high incidence of Hodgkin's - like reticulum cell neoplasm at 18 months of age and pituitary tumors in old multiparous females.

Other similar but truly Ph - negative conditions are considered CML - like myeloproliferative neoplasms.

«Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123 - Specific CAR T Cells: A First - in - Human Clinical Trial» is presented at the ASH Annual Meeting Dec. 9 to 12, 2017.

BAFF Levels Are Elevated in Paediatric Patients With Acute Lymphoblastic Leukaemia Compared to Other B - Lineage Neoplasms

Gene expression profiling of pulmonary neuroendocrine neoplasms: A comprehensive overview.

Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late - stage differentiation of normal B cells.

Abstract Neuroblastoma is an embryonal neoplasm arising from the peripheral nervous system that accounts for 15 % of cancer deaths in childhood.

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very aggressive type of cancer with multiple manifestations including skin lesions, abnormal cell counts and central nervous system (CNS) disease involvement.

Each neoplasm was part of a tissue microarray constructed as described elsewhere (22).

We screened the coding sequences of 518 protein kinases (approximately 1.3 Mb of DNA per sample) for somatic mutations in 26 primary lung neoplasms and seven lung cancer cell lines.

Supportive care is given to treat problems caused by multiple myeloma and other plasma cell neoplasms.

Also called neoplasm.

Several types of targeted therapy may be used to treat multiple myeloma and other plasma cell neoplasms.

In this type of plasma cell neoplasm, less than 10 % of the bone marrow is made up of abnormal plasma cells and there is no cancer.

Plasma cell neoplasms are diseases in which abnormal plasma cells or myeloma cells form tumors in the bones or soft tissues of the body.

Panobinostat is an HDAC inhibitor used in the treatment of multiple myeloma and other plasma cell neoplasms.

For more information from the National Cancer Institute about multiple myeloma and other plasma cell neoplasms, see the following:

Plasma cell neoplasms are most common in people who are middle aged or older.

The following types of plasma cell neoplasms are cancer:

Daratumumab and elotuzumab are monoclonal antibodies used in the treatment of multiple myeloma and other plasma cell neoplasms.

Bortezomib, carfilzomib, and ixazomib are proteasome inhibitors used in the treatment of multiple myeloma and other plasma cell neoplasms.